Pulmonx Corp是一家主营介入肺病学医疗解决方案的全球医疗科技企业,主打用于治疗慢性阻塞性肺疾病、肺气肿的微创支气管内瓣膜产品,业务覆盖北美、欧洲、亚太等市场,为重症肺病患者提供低创伤治疗选择。
DCTH
DELCATH SYSTEMS, INC.
营收
$20.7M
净利润
$-1.9M
SGHT
Sight Sciences, Inc.
$20.4M
$-4.2M
TELA
TELA Bio, Inc.
$20.9M
$-9.0M
BSVN
Bank7 Corp.
$24.1M
$10.8M
APYX
Apyx Medical Corp
$19.2M
$-1.3M
PDEX
PRO DEX INC
$18.7M
$2.2M
ZEO
Zeo Energy Corp.
$18.6M
$-2.0M
KMTS
KESTRA MEDICAL TECHNOLOGIES, LTD.
$22.6M
$-32.8M